Folate status, folate-related genes and serum miR-21 expression: Implications for miR-21 as a biomarker

BBA Clinical

Volumn 4, Issue , 2015, Pages 45-51

  Beckett, Emma Louise ^a,b   Martin, Charlotte ^a   Choi, Jeong Hwa ^a   King, Katrina ^c   Niblett, Suzanne ^c   Boyd, Lyndell ^a   Duesing, Konsta ^b   Yates, Zoe ^d   Veysey, Martin ^c   Lucock, Mark ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b CSIRO   (Australia)

^c Central Coast Local Health District   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Adenomatous polyps; Colorectal cancer; Folate; MicroRNA; MiR 21

Indexed keywords

FOLIC ACID; MICRORNA 21;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CARBON METABOLISM; CELL PROLIFERATION; COHORT ANALYSIS; COLON CANCER; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VERY ELDERLY;

EID: 84937554665     PISSN: 22146474     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbacli.2015.06.006     Document Type: Article

References (57)

1. Friedman R., Farh K., Burge C., Bartel D. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
2. Calin G., Croce C. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6.
3. Weiland M., Gao X., Zhou L., Mi Q. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol. 2012, 9:850-859.
4. Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., Yerushalmi N., Benjamin H., Kushnir M., Cholakh H., Melamed N., Bentwich Z., Hod M., Goren Y., Chajut A. Serum microRNAs are promising novel biomarkers. PLoS ONE 2008, 3:e3148.
5. Basati G., Emami Razavi A., Abdi S., Mirzaei A. Elevated level of microRNA-21 in the serum of patients with colorectal cancer. Med. Oncol. 2014, 31:205.
6. Li S., Yang X., Yang J., Zhen J., Zhang D. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis. Clin. Exp. Med. 2014.
7. Shen L., Wan Z., Ma Y., Wu L., Liu F., Zang H., Xin S. The clinical utility of microRNA-21 as novel biomarker for diagnosing human cancers. Tumour Biol. 2015, 36:1993-2005.
8. Wang G., Wang L., Sun S., Wu J., Wang Q. Quantitative measurement of serum microRNA-21 expression in relation to breast cancer metastasis in Chinese females. Ann. Lab. Med. 2015, 35:226-232.
9. Wu K., Li L., Li S. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies. Tumour Biol. 2015, 36:1973-1981.
10. Toiyama Y., Takahashi M., Hur K., Nagasaka T., Tanaka K., Inoue Y., Kusunoki M., Boland C.R., Goel A. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J. Natl. Cancer Inst. 2013, 105:849-859.
11. Wang J., Huang S.K., Zhao M., Yang M., Zhong J.L., Gu Y.Y., Peng H., Che Y.Q., Huang C.Z. Identification of a circulating microRNA signature for colorectal cancer detection. PLoS One 2014, 9. e87451.
12. Kanaan Z., Rai S.N., Eichenberger M.R., Roberts H., Keskey B., Pan J., Galandiuk S. Plasma miR-21: a potential diagnostic marker of colorectal cancer. Ann. Surg. 2012, 256:544-551.
13. Beckett E.L., Yates Z., Veysey M., Duesing K., Lucock M. The role of vitamins and minerals in modulating the expression of microRNA. Nutr. Res. Rev. 2014, 27:94-106.
14. Tarallo S., Pardini B., Mancuso G., Rosa F., Di Gaetano C., Rosina F., Vineis P., Naccarati A. MicroRNA expression in relation to different dietary habits: a comparison in stool and plasma samples. Mutagenesis 2014, 29:385-391.
15. Jorde R., Svartberg J., Joakimsen R.M., Coucheron D.H. Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12months. BMC Res. Notes 2012, 5:245.
16. Enquobahrie D.A., Williams M.A., Qiu C., Siscovick D.S., Sorensen T.K. Global maternal early pregnancy peripheral blood mRNA and miRNA expression profiles according to plasma 25-hydroxyvitamin D concentrations. J. Matern. Fetal Neonatal Med. 2011, 24:1002-1012.
17. Rimbach G., Moehring J., Huebbe P., Lodge J.K. Gene-regulatory activity of alpha-tocopherol. Molecules 2010, 15:1746-1761.
18. Ryu M.S., Langkamp-Henken B., Chang S.M., Shankar M.N., Cousins R.J. Genomic analysis, cytokine expression, and microRNA profiling reveal biomarkers of human dietary zinc depletion and homeostasis. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:20970-20975.
19. Davis C.D., Ross S.A. Evidence for dietary regulation of microRNA expression in cancer cells. Nutr. Rev. 2008, 66:477-482.
20. Ross S.A., Davis C.D. MicroRNA, nutrition, and cancer prevention. Adv. Nutr. 2011, 2:472-485.
21. Pogribny I.P., Tryndyak V.P., Ross S.A., Beland F.A. Differential expression of microRNAs during hepatocarcinogenesis induced by methyl deficiency in rats. Nutr. Rev. 2008, 66(Suppl 1):S33-S35.
22. Wang B., Majumder S., Nuovo G., Kutay H., Volinia S., Patel T., Schmittgen T.D., Croce C., Ghoshal K., Jacob S.T. Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology 2009, 50:1152-1161.
23. Kutay H., Bai S., Datta J., Motiwala T., Pogribny I., Frankel W., Jacob S.T., Ghoshal K. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J. Cell. Biochem. 2006, 99:671-678.
24. Alisi A., Da Sacco L., Bruscalupi G., Piemonte F., Panera N., De Vito R., Leoni S., Bottazzo G.F., Masotti A., Nobili V. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab. Investig. 2011, 91:283-293.
25. Kim Y.J., Hwang S.H., Cho H.H., Shin K.K., Bae Y.C., Jung J.S. MicroRNA 21 regulates the proliferation of human adipose tissue-derived mesenchymal stem cells and high-fat diet-induced obesity alters microRNA 21 expression in white adipose tissues. J. Cell. Physiol. 2012, 227:183-193.
26. Mudduluru G., George-William J.N., Muppala S., Asangani I.A., Kumarswamy R., Nelson L.D., Allgayer H. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci. Rep. 2011, 31:185-197.
27. Mandal C.C., Ghosh-Choudhury T., Dey N., Choudhury G.G., Ghosh-Choudhury N. miR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression. Carcinogenesis 2012, 33:1897-1908.
28. Vinciguerra M., Sgroi A., Veyrat-Durebex C., Rubbia-Brandt L., Buhler L.H., Foti M. Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes. Hepatology 2009, 49:1176-1184.
29. Hou N., Huo D., Dignam J.J. Prevention of colorectal cancer and dietary management. Chin. Clin. Oncol. 2013, 2:13.
30. Lucock M., Yates Z. Folic acid fortification: a double-edged sword. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12:555-564.
31. Lucock M., Yates Z., Martin C., Choi J.-H., Beckett E., Boyd L., LeGras K., Ng X., Skinner V., Wai R., Kho J., Roach P., Veysey M. Methylation diet and methyl group genetics in risk for adenomatous polyp occurrence. BBA Clin. 2015, 3:107-112.
32. Niculescu M.D., Zeisel S.H. Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J. Nutr. 2002, 132:2333S-2335S.
33. Stefanska B., Karlic H., Varga F., Fabianowska-Majewska K., Haslberger A. Epigenetic mechanisms in anti-cancer actions of bioactive food components-the implications in cancer prevention. Br. J. Pharmacol. 2012, 167:279-297.
34. Ulrich C.M. Folate and cancer prevention: a closer look at a complex picture. Am. J. Clin. Nutr. 2007, 86:271-273.
35. Haggar F.A., Boushey R.P. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin. Colon Rectal Surg. 2009, 22:191-197.
36. Lucock M., Yates Z., Martin C., Choi J.H., Boyd L., Tang S., Naumovski N., Roach P., Veysey M. Hydrogen sulphide-related thiol metabolism and nutrigenetics in relation to hypertension in an elderly population. Genes Nutr. 2013, 8:221-229.
37. Ng X., Boyd L., Dufficy L., Naumovski N., Blades B., Travers C., Lewis P., Sturm J., Yates Z., Townley-Jones M., Roach P., Veysey M., Lucock M. Folate nutritional genetics and risk for hypertension in an elderly population sample. J. Nutrigenet. Nutrigenomics 2009, 2:1-8.
38. Tan Y., Hoffman R.M. A highly sensitive single-enzyme homocysteine assay. Nat. Protoc. 2008, 3:1388-1394.
39. Hastings M.L., Palma J., Duelli D.M. Sensitive PCR-based quantitation of cell-free circulating microRNAs. Methods 2012, 58:144-150.
40. Beckett E.L., Martin C., Duesing K., Yates Z., Veysey M., Lucock M. Vitamin D receptor genotype modulates the correlation between vitamin D and circulating levels of let-7a/b and vitamin D intake in an elderly cohort. J. Nutrigenet. Nutrigenomics 2014, 7:264-273.
41. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B., Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10513-10518.
42. Balcells I., Cirera S., Busk P.K. Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers. BMC Biotechnol. 2011, 11:70.
43. Hellemans J., Mortier G., De Paepe A., Speleman F., Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007, 8:R19.
44. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol. Clin. N. Am. 2002, 31:925-943.
45. Neugut A.I., Garbowski G.C., Lee W.C., Murray T., Nieves J.W., Forde K.A., Treat M.R., Waye J.D., Fenoglio-Preiser C. Dietary risk factors for the incidence and recurrence of colorectal adenomatous polyps. A case-control study. Ann. Intern. Med. 1993, 118:91-95.
46. Lee J.E., Willett W.C., Fuchs C.S., Smith-Warner S.A., Wu K., Ma J., Giovannucci E. Folate intake and risk of colorectal cancer and adenoma: modification by time. Am. J. Clin. Nutr. 2011, 93:817-825.
47. A.I.o.H.a Welfare, Mandatory Folic Acid and Iodine Fortification in Australia and New Zealand: Supplement to the Baseline Report for Monitoring 2011, AIHW., Canberra. C.n.P. 153 (Ed.).
48. Chen J., Giovannucci E., Hankinson S.E., Ma J., Willett W.C., Spiegelman D., Kelsey K.T., Hunter D.J. A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 1998, 19:2129-2132.
49. Curtin K., Bigler J., Slattery M.L., Caan B., Potter J.D., Ulrich C.M. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol. Biomark. Prev. 2004, 13:285-292.
50. Kim J., Cho Y.A., Kim D.H., Lee B.H., Hwang D.Y., Jeong J., Lee H.J., Matsuo K., Tajima K., Ahn Y.O. Dietary intake of folate and alcohol, MTHFR C677T polymorphism, and colorectal cancer risk in Korea. Am. J. Clin. Nutr. 2012, 95:405-412.
51. Le Marchand L., Wilkens L.R., Kolonel L.N., Henderson B.E. The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol. Biomark. Prev. 2005, 14:1198-1203.
52. Levine A.J., Figueiredo J.C., Lee W., Poynter J.N., Conti D., Duggan D.J., Campbell P.T., Newcomb P., Martinez M.E., Hopper J.L., Le Marchand L., Baron J.A., Limburg P.J., Ulrich C.M., Haile R.W. Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registry. Cancer Epidemiol. Biomark. Prev. 2010, 19:89-100.
53. Ma J., Stampfer M.J., Giovannucci E., Artigas C., Hunter D.J., Fuchs C., Willett W.C., Selhub J., Hennekens C.H., Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 1997, 57:1098-1102.
54. Slattery M.L., Potter J.D., Samowitz W., Schaffer D., Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol. Biomark. Prev. 1999, 8:513-518.
55. Ulrich C.M., Curtin K., Potter J.D., Bigler J., Caan B., Slattery M.L. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol. Biomark. Prev. 2005, 14:2509-2516.
56. Fallon U.B. Commentary: colon cancer, folate and genetic status. Int. J. Epidemiol. 2003, 32:67-70.
57. Liu A.Y., Scherer D., Poole E., Potter J.D., Curtin K., Makar K., Slattery M.L., Caan B.J., Ulrich C.M. Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Mol. Nutr. Food Res. 2013, 57:721-734.